Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2005

Activities of red blood cell anti-oxidative enzymes (SOD, GPx) and total anti-oxidativecapacity of serum (TAS) in men with coronary atherosclerosis and in healthy pilots.

Ewelina Zawadzka-Bartczak

Med Sci Monit 2005; 11(9): CR440-444 :: ID: 428453

Abstract

Background: Reactive oxygen species (ROS) have been proposed to play importantpathogenic roles, especially in harmful oxidative modifications of low-density cholesterol. Redox balancewithin the organism is largely determined by the activities of anti-oxidative enzymes of red blood cellsand by the total anti-oxidative capacity of the serum (TAS). Material/Methods: SOD and GPx activitiesand TAS in 13 men aged 42-65 years with coronary atherosclerosis (group I) were compared with those ofboth 15 clinically healthy pilots matched for age and lipid abnormalities (cholesterol and triglycerides)(group II) and 14 age-matched pilots without lipid abnormalities (group III). Results: There were statisticallysignificant differences in SOD and GPx activities and in TAS between the groups. Conclusions: 1. SODand GPx activities and TAS were lower in men with advanced coronary atherosclerosis that in age-matchedclinically healthy men with similar dyslipidemia and were even further decreased compared with clinicallyhealthy men without dyslipidemia. 2. The decrease in SOD and GPx activities and TAS in men with advancedcoronary atherosclerosis was more pronounced than the degree of hypercholesterolemia or hypertriglyceridemia.3. If hyperlipidemia and the activity of antioxidative enzymes and TAS were considered without referenceto other risk factors of atherosclerosis, it appeared that the decreases in SOD, GPx, and TAS may playa more important role in the development of the atherosclerotic process than isolated increases in freecholesterol or triglyceride levels.

Keywords: Aerospace Medicine, Antioxidants - metabolism, Case-Control Studies, Cholesterol - blood, Coronary Artery Disease - enzymology, Erythrocytes - enzymology, Glutathione Peroxidase - blood, Reactive Oxygen Species - blood, Superoxide Dismutase - blood, Triglycerides - blood

Add Comment 0 Comments

Editorial

01 April 2024 : Editorial  

Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance

Dinah V. Parums

DOI: 10.12659/MSM.944600

Med Sci Monit 2024; 30:e944600

0:00

In Press

08 Mar 2024 : Clinical Research  

Evaluation of Foot Structure in Preschool Children Based on Body Mass

Med Sci Monit In Press; DOI: 10.12659/MSM.943765  

0:00

15 Apr 2024 : Laboratory Research  

The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in Osteoarthritis

Med Sci Monit In Press; DOI: 10.12659/MSM.943738  

0:00

07 Mar 2024 : Clinical Research  

Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...

Med Sci Monit In Press; DOI: 10.12659/MSM.943468  

08 Mar 2024 : Animal Research  

Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...

Med Sci Monit In Press; DOI: 10.12659/MSM.943443  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750